Trials that use: Risk difference
New to this method? Read the tutorial →
4,772 results
- Esmolol or Nitroglycerin Infusion for Blood Pressure Control Prior to Cardiopulmonary Bypass (CPB) in Cardiac Surgery: Complete Statistical AnalysisIndependent statistical analysis of Esmolol or Nitroglycerin Infusion for Blood Pressure Control Prior to Cardiopulmonary Bypass (CPB) in Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ESS-NSPASIndependent statistical analysis of A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test: primary endpoint results, effect estimate with confidence interval, sample-size…
- Establishing Functional Biomarkers for Spaced Theta-Burst Stimulation: Complete Statistical AnalysisIndependent statistical analysis of Establishing Functional Biomarkers for Spaced Theta-Burst Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03687892).
- ESTRELLAIndependent statistical analysis of A Study of Belcesiran in Patients With AATLD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04764448).
- Estrogen for Triple Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Estrogen for Triple Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01083641).
- ET-01 in Subjects With Lateral Canthal Lines: Complete Statistical AnalysisIndependent statistical analysis of ET-01 in Subjects With Lateral Canthal Lines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03326856).
- ETA-TVIndependent statistical analysis of EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02877732).
- Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan): Complete Statistical AnalysisIndependent statistical analysis of Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01230177).
- Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab: Complete Statistical AnalysisIndependent statistical analysis of Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Etirinotecan Pegol (NKTR-102) in NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Etirinotecan Pegol (NKTR-102) in NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01773109).
- Etoposide in Patients With COVID-19 Infection: Complete Statistical AnalysisIndependent statistical analysis of Etoposide in Patients With COVID-19 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04356690).
- Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer: Complete Statistical AnalysisIndependent statistical analysis of Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EU RCTIndependent statistical analysis of ILLUMENATE EU Randomized Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01858363).
- EURORELAXIndependent statistical analysis of Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04124757).
- EUS-CNB Versus EUS-SINK for Diagnosis of Upper Gastrointestinal (UGI) Subepithelial Tumors: Complete Statistical AnalysisIndependent statistical analysis of EUS-CNB Versus EUS-SINK for Diagnosis of Upper Gastrointestinal (UGI) Subepithelial Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EV ICDIndependent statistical analysis of Extravascular ICD Pivotal Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04060680).
- EVA-VRS01Independent statistical analysis of A Study to Assess Safety, Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- EVACELIndependent statistical analysis of Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01678664).
- EVADEComplete statistical analysis of the randomized phase 2/3 EVADE trial of ADG20 for the prevention of COVID-19, including trial design, primary and secondary endpoints, risk differences, hazard ratios, statistical methodology, safety, and…
- Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation: Complete Statistical AnalysisIndependent statistical analysis of Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02348684).
- Evaluate Effects of Personalized Patient Counselling for Enbrel® Therapy in Adults With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Evaluate Effects of Personalized Patient Counselling for Enbrel® Therapy in Adults With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluate Safety of Tramadol in the Management of Postoperative Pain Following Surgery: Complete Statistical AnalysisIndependent statistical analysis of Evaluate Safety of Tramadol in the Management of Postoperative Pain Following Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluate Severe Hepatic Impairment on Dacomitinib PK: Complete Statistical AnalysisIndependent statistical analysis of Evaluate Severe Hepatic Impairment on Dacomitinib PK: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03865446).
- Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Lomitapide in Healthy Subjects.: Complete Statistical AnalysisIndependent statistical analysis of Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Lomitapide in Healthy Subjects.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluate the Performance and Safety of Comet Pressure Guidewire in the Measurement of FFR: Complete Statistical AnalysisIndependent statistical analysis of Evaluate the Performance and Safety of Comet Pressure Guidewire in the Measurement of FFR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-naïve Adult Male Patients With Fabry Disease: Complete Statistical AnalysisIndependent statistical analysis of Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-naïve Adult Male Patients With Fabry Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression: Complete Statistical AnalysisIndependent statistical analysis of Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Evaluating Cancer Survivorship Care Models: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Cancer Survivorship Care Models: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02362750).
- Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02982720).
- Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Evaluating Immune Response to Seasonal FluMist in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Immune Response to Seasonal FluMist in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01673425).
- Evaluating Online Messages About Colon Cancer Screening: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Online Messages About Colon Cancer Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06134089).
- Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01415583).
- Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen: Complete Statistical AnalysisIndependent statistical analysis of Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec: Complete Statistical AnalysisIndependent statistical analysis of Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluating Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA: primary endpoint results, effect estimate with confidence interval, sample-size…
- Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluating the Ease of Use of a VAC GranuFoam Bridge Dressing on Diabetic Foot Ulcers Receiving VAC Negative Pressure Wound Therapy: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Ease of Use of a VAC GranuFoam Bridge Dressing on Diabetic Foot Ulcers Receiving VAC Negative Pressure Wound Therapy: primary endpoint results, effect estimate with confidence…
- Evaluating the Effect of Chronic Antihypertensive Therapy on Vasopressor Dosing in Septic Shock: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Effect of Chronic Antihypertensive Therapy on Vasopressor Dosing in Septic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection: primary endpoint results, effect…
- Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2): Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluating the Impact of Patient Photographs for Preventing Wrong-Patient Errors: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Impact of Patient Photographs for Preventing Wrong-Patient Errors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03626766).
- Evaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2/1030s) in RSV-Seropositive Children and RSV-Seronegative Infants and Children: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2/1030s) in RSV-Seropositive Children and RSV-Seronegative Infants and Children: primary endpoint results, effect estimate with…
- Evaluating the Need for Pneumatic Compression Devices: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Need for Pneumatic Compression Devices: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02641080).
- Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS).: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluating the Safety and Efficacy of Fractionated Carbon Dioxide Therapy in Postoperative Lower Extremity Wound Healing: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Efficacy of Fractionated Carbon Dioxide Therapy in Postoperative Lower Extremity Wound Healing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…